1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Lymphopenia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ind, PW; Johnston, SR; Seale, J; Spring, J | 1 |
1 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Lymphopenia
| Article | Year |
|---|---|
Failure of salmeterol to inhibit circulating white cell responses and bronchoconstriction induced by platelet activating factor.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Bronchoconstriction; Double-Blind Method; Female; Humans; Inflammation; Leukocyte Count; Lymphocytes; Lymphopenia; Male; Neutrophils; Platelet Activating Factor; Salmeterol Xinafoate | 1992 |